Obstetrics & Gynecology

News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Weill Cornell Medicine Scientist Receives Award for Research on New Ovarian Cancer Targets

Microscopic image of ovarian cancer cells, illustrated in purple

Dr. Dan Landau, the Bibliowicz Family Professor of Medicine, and a member of the Sandra and Edward Meyer Cancer Center and the Englander Institute for Precision Medicine at Weill Cornell Medicine, has received a Lotus Award from the Pershing Square Foundation for research aimed at uncovering new immunotherapy targets in ovarian cancer.

The Pershing Square Foundation supports ambitious cancer research projects, and since 2025 has been funding ovarian cancer research with three-year grants of $750,000, now called Lotus Awards. Awardees were selected for their scientific rigor, originality and potential to drive meaningful advances in a disease where progress is urgently needed. Dr. Landau is one of eight recipients this year.

“We’re grateful for this opportunity to develop new therapeutic perspectives to benefit patients with this deadly but relatively under-studied form of cancer,” said Dr. Landau, who is also a core faculty member of the New York Genome Center.

Metal-Free Carbon Monoxide Prodrugs May Help Prevent Cancer’s Deadly Spread

metastatic cancer cells

Video of CO Podcast Animation

A carefully designed metal-free carbon monoxide prodrug—an inactive compound that is converted into its active form in the body—may help prevent some of the deadliest forms of cancer from spreading, according to researchers at Weill Cornell Medicine. The recent preclinical study, published in Advanced Science, offers a new strategy to potentially reduce the recurrence of pancreatic and triple-negative breast cancer in patients who initially respond to treatment.

Even after surgery and chemotherapy, microscopic cancer cells may survive and later establish new tumors in distant organs. Researchers have long pursued treatments that can safely block this process.

Dr. Nancy Du

Dr. Nancy Du

An Opportunity to Strengthen Key Health Measures in National Climate Plans

woman holding poster saying climate emergency equals health emergency

The majority of national climate adaptation plans fail to fully integrate health needs or engage populations most at risk from climate change, found an international team of investigators led by Weill Cornell Medicine.

The study was published on June 10 in Lancet Planetary Health. Senior author Dr. Ilan Cerna-Turoff, assistant professor of epidemiology in emergency medicine at Weill Cornell Medicine, and his study team reviewed climate adaptation policies from 198 countries and the European Union, finding that while 88% mentioned the health impacts of climate change, important gaps in health integration remain. Progress on health integration was variable, with several regions of the world falling behind. Some health conditions were nearly absent. Despite the widespread recognition that specific demographic groups were disproportionately affected by the health impacts of climate change, only 12% of the plans engaged these groups in their efforts. Many plans also lacked sufficient budgeting for monitoring and evaluation and health-related climate actions.

Contact Us